Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 1
Abstract
The article presents data on epidemiology, risk factors, mechanisms of development, clinical features of cognitive impairment in patients with type 2 diabetes mellitus. The literature data about the dependence of the incidence and severity of cognitive impairment on the type of hypoglycemic therapy are analyzed. As well as the results of clinical and experimental studies concerning the peculiarities of cognitive functions against the background of using various antidiabetic agents — meglitinides, biguanides, thiazolidinediones, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, sodium-dependent glucose cotransporter 2 inhibitors and insulin.
Authors and Affiliations
N. V. Pashkovska
Keywords
Related Articles
- EP ID EP275725
- DOI 10.22141/2224-0721.14.1.2018.127097
- Views 75
- Downloads 0
Epidemiology and Morphological Features of Thyroid Cancer in People Living in Vinnytsia Region
Background. Thyroid cancer (TC) is the most common tumor of the endocrine glands. The problem of thyroid cancer in Ukraine went far beyond the consequences of the Chernobyl disaster and is characterized by increasing mor...
A Case of Primary Hyperparathyroidism Combined with Cushing Syndrome due to Ectopic ACTH Secretion
A rare case of primary hyperparathyroidism (PHPT) combined with Cushing syndrome due to ectopic ACTH secretion in 37-year-old women is described. The patient gradually underwent surgeries after compensation of general co...
Autoimmune polyglandular syndrome type 2 (clinical case of Сarpenter syndrome)
Carpenter syndrome is a rare autoimmune disease that is associated with impaired function of several endocrine organs (diabetes mellitus, chronic adrenal insufficiency and/or autoimmune thyroiditis). A case of atypical c...
Role of thyroid gland in metabolic syndrome and in combination with chronic coronary heart disease and type 2 diabetes mellitus
Background. Metabolic syndrome (MS) is a topical issue of 21st century, a criterion for type 2 diabetes mellitus (DM) and coronary heart disease (CHD) severity. Violations of lipid, carbohydrate exchange and hormonal sta...
Assessment of Glycemia Impact on the Parameters of Sleep in Type 1 Diabetes Mellitus: the Results of Cross-Sectional Cohort Trial
This study demonstrates the impact of glycemia according to daily monitoring of blood glucose on parameters of nocturnal sleep in type 1 diabetic patients, regardless of the glycated haemoglobin level.